Price T Rowe Associates Inc Milestone Pharmaceuticals Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$5.22 - $6.11 $1.4 Million - $1.64 Million
-267,997 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$5.79 - $8.85 $619,298 - $946,596
-106,960 Reduced 28.53%
267,997 $1.55 Million
Q4 2020

Feb 16, 2021
BUY
$5.57 - $7.66 $2.09 Million - $2.87 Million
374,957 New
374,957 $2.51 Million

Others Institutions Holding MIST

# of Institutions
44
Shares Held
28.6M
Call Options Held
200
Put Options Held
0
View Full List

About Milestone Pharmaceuticals Inc.

MIST Quotes by TradingView
  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $55.2M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email